Drugs / RC-01
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03832517 Comparator | Apr 2019 | — | Recida Therapeutics, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RC-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03832517 ↗ |
| Route | Intravenous | “Intravenous single escalating doses of RC-01” NCT03832517 ↗ |